FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2292297312> ?p ?o ?g. }

• W2292297312 endingPage "900" @default.
• W2292297312 startingPage "889" @default.
• W2292297312 abstract "Exendin-4 (ex-4) is a long-acting glucagon-like peptide-1 receptor (GLP-1R) agonist which exerts beneficial effects on glycemic control and promotes cell viability. In the present study, we investigated the anti-apoptotic effects of ex-4, as well as the potential mechanisms responsible for these effects in rat bone marrow-derived mesenchymal stem cells (BM-MSCs) under conditions of oxygen, glucose and serum deprivation (OGD). The apoptosis of the MSCs was induced by subjecting the cells to OGD conditions for 4 h and was detected by Annexin V/PI and Hoechst 33258 staining. The MSCs were pre-conditioned with ex-4 for 12 h prior to being subjected to OGD conditions, and the expression levels of an apoptotic marker (cleaved caspase-3), endoplasmic reticulum (ER) stress markers [phosphorylated (p-)protein kinase RNA-like endoplasmic reticulum kinase (PERK), PERK, binding immunoglobulin protein (BIP), activating transcription factor 4 (ATF-4) and C/EBP homologous protein (CHOP)], as well as those of a survival marker (Bcl-2) were measured by western blot analysis. Furthermore, the mRNA levels of ATF-4 and CHOP were determined by RT-qPCR. ELISA was used to examine the activity of intracellular cAMP. Moreover, the GLP-1R antagonist, exendin9-39 (ex9-39), the protein kinase A (PKA) inhibitor, H89, and small interfering RNA (siRNA) targeting rat ATF-4 and CHOP were co-incubated with the MSCs. The apoptotic rate was markedly diminished following pre-conditioning with ex-4 in a dose‑dependent manner (P<0.05). The ER stress markers, p-PERK, BIP, ATF-4 and CHOP, were upregulated in the cells subjected to OGD conditions. Ex-4 pre-conditioning significantly decreased the mRNA and protein levels of ATF-4 and CHOP (P<0.05), and increased the activity of intracellular cAMP (P<0.05). Furthermore, the anti-apoptotic effects of ex-4 were almost reversed by treatment with either H89 or ex9-39 (P<0.05); transfection with siRNA-CHOP significantly reduced the apoptotic rate of the MSCs and did not impair the cytoprotective effects of ex-4. Taken together, these findings suggest that ex-4 protects rat BM-MSCs from OGD-induced apoptosis through the activation of the PKA/cAMP pathway and the attenuation of the ER stress signaling pathway. Ex-4 may thus prove to be a therapeutic agent with the potential to improve the viability of MSCs in the ischemic milieu, and consequently, to optimize the therapeutic effects of MSC therapy in acute myocardial infarction." @default.
• W2292297312 created "2016-06-24" @default.
• W2292297312 creator A5004324240 @default.
• W2292297312 creator A5018728349 @default.
• W2292297312 creator A5030228661 @default.
• W2292297312 creator A5039568551 @default.
• W2292297312 creator A5043389655 @default.
• W2292297312 creator A5049353863 @default.
• W2292297312 creator A5059483904 @default.
• W2292297312 creator A5080723807 @default.
• W2292297312 creator A5083582403 @default.
• W2292297312 date "2016-02-29" @default.
• W2292297312 modified "2023-10-11" @default.
• W2292297312 title "Exendin-4 protects bone marrow-derived mesenchymal stem cells against oxygen/glucose and serum deprivation-induced apoptosis through the activation of the cAMP/PKA signaling pathway and the attenuation of ER stress" @default.
• W2292297312 cites W1954373103 @default.
• W2292297312 cites W1969759659 @default.
• W2292297312 cites W197648304 @default.
• W2292297312 cites W1977603207 @default.
• W2292297312 cites W1979043688 @default.
• W2292297312 cites W1984033663 @default.
• W2292297312 cites W1984740259 @default.
• W2292297312 cites W1987503760 @default.
• W2292297312 cites W1988091867 @default.
• W2292297312 cites W1994056283 @default.
• W2292297312 cites W2025511820 @default.
• W2292297312 cites W2032221859 @default.
• W2292297312 cites W2038109543 @default.
• W2292297312 cites W2045846363 @default.
• W2292297312 cites W2052921250 @default.
• W2292297312 cites W2067591094 @default.
• W2292297312 cites W2072935519 @default.
• W2292297312 cites W2074349946 @default.
• W2292297312 cites W2089450643 @default.
• W2292297312 cites W2091395040 @default.
• W2292297312 cites W2098234683 @default.
• W2292297312 cites W2100347985 @default.
• W2292297312 cites W2107076497 @default.
• W2292297312 cites W2115860183 @default.
• W2292297312 cites W2122340479 @default.
• W2292297312 cites W2123844577 @default.
• W2292297312 cites W2127409471 @default.
• W2292297312 cites W2132600402 @default.
• W2292297312 cites W2136954841 @default.
• W2292297312 cites W2139568257 @default.
• W2292297312 cites W2142097676 @default.
• W2292297312 cites W2154254659 @default.
• W2292297312 cites W2155572920 @default.
• W2292297312 cites W2160495818 @default.
• W2292297312 cites W2160574753 @default.
• W2292297312 cites W2169872175 @default.
• W2292297312 cites W2321413400 @default.
• W2292297312 cites W2559680414 @default.
• W2292297312 doi "https://doi.org/10.3892/ijmm.2016.2509" @default.
• W2292297312 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4790651" @default.
• W2292297312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26935620" @default.
• W2292297312 hasPublicationYear "2016" @default.
• W2292297312 type Work @default.
• W2292297312 sameAs 2292297312 @default.
• W2292297312 citedByCount "35" @default.
• W2292297312 countsByYear W22922973122016 @default.
• W2292297312 countsByYear W22922973122017 @default.
• W2292297312 countsByYear W22922973122018 @default.
• W2292297312 countsByYear W22922973122019 @default.
• W2292297312 countsByYear W22922973122020 @default.
• W2292297312 countsByYear W22922973122021 @default.
• W2292297312 countsByYear W22922973122022 @default.
• W2292297312 countsByYear W22922973122023 @default.
• W2292297312 crossrefType "journal-article" @default.
• W2292297312 hasAuthorship W2292297312A5004324240 @default.
• W2292297312 hasAuthorship W2292297312A5018728349 @default.
• W2292297312 hasAuthorship W2292297312A5030228661 @default.
• W2292297312 hasAuthorship W2292297312A5039568551 @default.
• W2292297312 hasAuthorship W2292297312A5043389655 @default.
• W2292297312 hasAuthorship W2292297312A5049353863 @default.
• W2292297312 hasAuthorship W2292297312A5059483904 @default.
• W2292297312 hasAuthorship W2292297312A5080723807 @default.
• W2292297312 hasAuthorship W2292297312A5083582403 @default.
• W2292297312 hasBestOaLocation W22922973121 @default.
• W2292297312 hasConcept C126322002 @default.
• W2292297312 hasConcept C134018914 @default.
• W2292297312 hasConcept C139447449 @default.
• W2292297312 hasConcept C153911025 @default.
• W2292297312 hasConcept C158617107 @default.
• W2292297312 hasConcept C184235292 @default.
• W2292297312 hasConcept C190283241 @default.
• W2292297312 hasConcept C198826908 @default.
• W2292297312 hasConcept C2779725641 @default.
• W2292297312 hasConcept C553184892 @default.
• W2292297312 hasConcept C55493867 @default.
• W2292297312 hasConcept C71924100 @default.
• W2292297312 hasConcept C86803240 @default.
• W2292297312 hasConcept C88634738 @default.
• W2292297312 hasConcept C95444343 @default.
• W2292297312 hasConcept C97029542 @default.
• W2292297312 hasConceptScore W2292297312C126322002 @default.
• W2292297312 hasConceptScore W2292297312C134018914 @default.
• W2292297312 hasConceptScore W2292297312C139447449 @default.
• W2292297312 hasConceptScore W2292297312C153911025 @default.

• next